Crisil, ICRA reaffirm credit rating, underscore confidence in business stability, says Vedanta
on Friday said rating agencies
Crisil Ratings
and
ICRA
have reaffirmed their credit ratings, underscoring continued confidence in the mining major's overall
business stability
.
In a regulatory filing, Vedanta said
ICRA
Ltd has reaffirmed the company's credit ratings, underscoring continued confidence in Vedanta's overall business stability and healthy financial performance, healthy
financial performance
and strong adherence to corporate governance.
Explore courses from Top Institutes in
Select a Course Category
Public Policy
MCA
Artificial Intelligence
Data Science
Healthcare
Degree
healthcare
MBA
Design Thinking
Operations Management
PGDM
Product Management
Others
Cybersecurity
Project Management
Data Analytics
Technology
Digital Marketing
others
CXO
Leadership
Finance
Data Science
Management
Skills you'll gain:
Duration:
12 Months
IIM Calcutta
Executive Programme in Public Policy and Management
Starts on
undefined
Get Details
Skills you'll gain:
Economics for Public Policy Making
Quantitative Techniques
Public & Project Finance
Law, Health & Urban Development Policy
Duration:
12 Months
IIM Kozhikode
Professional Certificate Programme in Public Policy Management
Starts on
Mar 3, 2024
Get Details
Vedanta said that ICRA has reaffirmed its long-term rating at AA.
In another filing Vedanta said, "Crisil Ratings Ltd ... has reaffirmed the company's credit ratings, underscoring continued confidence in Vedanta's overall business stability and healthy financial performance."
The rating agency reaffirmed its long-term ratings of Crisil AAA for
Hindustan Zinc
Ltd and Crisil AA for Vedanta.
Live Events
Crisil Ratings said that it has taken note of the recent short-seller report and, after independent evaluation, reaffirmed Vedanta's ratings, according to the regulatory filing.
"CRISIL has its credit ratings outstanding on multiple entities of the Vedanta group, and all have been reaffirmed. Further, based on independent feedback, CRISIL understands that currently there has been no adverse reaction from any lender or investor," it said.
The filing further said that ICRA draws comfort from the group's stated commitment to ongoing debt reduction.
"The leverage ratio (Net Debt/OPBDITA), including Vedanta Resources Limited's debt, improved to 2.5x in FY 2025, down from 3.2x in FY 2024. Further, Vedanta's healthy profitability, particularly in its aluminium and zinc operations, continues to strengthen its credit profile. Additionally, the recent refinancing at VRL has effectively smoothened the debt maturity profile and is expected to reduce finance costs from FY 2026 onwards," the filing said.
US short seller Viceroy Research had last week released a report charging billionaire Anil Agarwal's mining conglomerate to be "financially unsustainable" and posing a severe risk to creditors, allegations which the group called "selective misinformation and baseless" aimed at discrediting the group.
Responding to the report, Vedanta in a statement had said, "The report is a malicious combination of selective misinformation and baseless allegations to discredit the Group".
"It has been issued without making any attempt to contact us with the sole objective of creating false propaganda. It only contains a compilation of various information, which is already in the public domain, but the authors have tried to sensationalise the context to profiteer from market reaction," it had said. PTI SID MR
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
5 hours ago
- Indian Express
Hindustan Zinc pays out as dividend more than it earns, alleges US research firm Viceroy
US-based Viceroy Research has alleged that Hindustan Zinc Ltd (HZL), belonging to the Vedanta group led by Anil Agarwal, has paid out far more in dividends than it earned, purportedly borrowing to make up the shortfall. The research house has estimated a shortfall in free cash flow (FCF) of HZL — once a public sector firm — in the first quarter ended June 2025 to be around Rs 3,600 crore ($371m). 'HZL CFO Sandeep Modi's 'Rs 10,000 crore ($1.17b) free cash flow' claim collapses under scrutiny. Cash flows are subsidized by debt. If HZL's dividend remains the same as last year, we estimate HZL will incur an annual FCF shortfall of at least Rs 5,000 crore ($580m) and must be funded by more debt,' it said. When contacted, HZL spokesperson said. 'the Viceroy report is a combination of selective misinformation and baseless allegations. All resolutions are detailed and part of Board undertakings which are taken to them after rigorous due diligence. In the past 20 years the company's zinc production capacity has grown more than 4 times and silver by 20 times.' 'Hindustan Zinc is steered through a stringent governance framework wherein all matters are taken to the Board and this process is followed for all proposals,' HZL said. Viceroy alleged that HZL has not generated Rs 10,000 crore in FCF since 2023, at which point FCF has fallen sequentially. On an annualized run rate: we expect HZL FCF at Rs 7,000 crore. In FY 23, during a short commodities rally post covid, HZL generated Rs 12,000 crore FCF, and paid Rs 31,000 crore in dividends, accruing an enormous deficit. Leverage increased sharply vs Q1 2024, with the debt-equity ratio rising from 0.8x to 1.2x. FCF represents the amount of cash a business generates after accounting for capital expenditures needed to maintain or expand its asset base. In simpler terms, it's the cash left over after a company pays for its operating expenses and investments in equipment, property, or other assets. Vedanta acquired HZL from the government in 2002. Disclosures suggest HZL incurred Rs 2,000 crore ($232m) of new debt in the June quarter of FY26. HZL's auditor, SR Batliboi, failed to investigate material concerns, relying entirely on management assertions while the company's capital base deteriorated and governance collapsed, Viceroy alleged. HZL spokesperson said it has become the world's largest integrated zinc producer and is amongst the top 5 primary silver producers. 'It has created immense stakeholder value through increase in market cap by more than 500 times, in addition to dividends to shareholders and exchequer contribution. HZL contributes nearly 35 percent of the declared dividend to the government treasury, including dividend to government and tax deducted at source (TDS),' he said. According to HZL, this quarter amidst commodity headwinds the company delivered beyond market expectations and registered record high first quarter mined metal production and lowest cost of production. In FY25, the company clocked its second-best profit, up 33% YoY. Hindustan Zinc's bank facilities and debt programmes are Crisil AAA rated highlighting our efficient & integrated operations, and strong financial risk profile. And this consistent performance reflects the growing trust of our stakeholders, HZL said. The research firm also questioned the brand fees paid out by HZL. In the earnings call, HZL's CEO Arun Misra 'credited offshore brand fees (paid in advance) as justifiable by past 'risks' undertaken by Vedanta as a shareholder of HZL. This is preposterous,' the research firm said. 'HZL CEO Arun Misra's defense of the controversial 3 per cent brand fee, a fee that results in hundreds of crores in annual payments to VRL (Vedanta Resources), was the centrepiece of his narrative during the Q1FY26 Earnings Call,' the US firm said. 'We reiterate our belief that this 'brand fee' is an uncommercial contract with VEDL (Vedanta Ltd), who does not appear to provide any brand, management, or other auxiliary services to HZL. There are no employees or substantial operations at VRL to justify brand fee payments,' Viceroy said. 'Vedanta's shares in HZL bear the same risk as every other equity holder, including the government of India. If anything, it is the non-promoter shareholders that have borne the outsized risk of HZL taking outsized loans to bail out promoters,' it alleged. HZL said 'Vedanta' is a prominent global brand in the natural resources sector and the brand is a registered intellectual property of Vedanta Resources. 'HZL and other group companies use the brand under a brand license/sub-license agreement and pay a Board-approved brand and strategic services fee for its usage. This structure reflects a standard intercompany licensing model used globally by diversified groups and is fully compliant with Indian accounting, tax and governance regulations, and follows internationally accepted practices,' HZL spokesperson said.
&w=3840&q=100)
Business Standard
12 hours ago
- Business Standard
ICRA downgrades NIIF backed Radiance Renewables' long term rating
Rating agency ICRA has downgraded NIIF-backed Radiance Renewables Private Ltd's (RRPL's) long-term rating from 'A' to 'A-' due to moderation in its credit profile and delays in capacity additions. The downgrade factors in the weakening of credit metrics following the use of additional mezzanine debt of Rs 525 crore in July 2025 to fund equity requirements for ongoing projects, and the slower-than-expected progress in capacity additions. The agency also revised the outlook on the ratings from 'stable' to 'negative', citing modest credit metrics. It affirmed the short-term rating at 'A2+'. RRPL, a renewable energy firm, is a 100 per cent subsidiary of Green Growth Equity Fund (GGEF), which counts the National Infrastructure and Investment Fund (NIIF) and the Government of the United Kingdom among its anchor investors. The company posted a loss of Rs 120.8 crore on operating income of Rs 557.5 crore in FY25. It had reported a loss of Rs 75.3 crore on operating income of Rs 409.1 crore in FY24. ICRA said in a statement that the company availed a mezzanine debt of Rs 525 crore in July 2025, of which Rs 185 crore has been used to repay an earlier mezzanine debt. The remaining amount will fund the equity requirements of upcoming projects in its subsidiaries. Delays in securing incremental equity funding have constrained progress on planned expansion. RRPL had an operational solar power capacity of 610 Megawatt Peak (MWp) as of June 2025, a modest rise from approximately 500 MWp in May 2024, due to delays in land acquisition and fund-raising. Additionally, the company has an under-construction capacity of around 250 MWp and a near-term pipeline of about 256 MWp. This will take the overall installed solar capacity to approximately 1,100 MWp over the next 12–15 months. RRPL aims to scale capacity further to 2,000 MWp by FY28. In this context, ICRA said the ability to raise equity to fund expansion and refinance the mezzanine debt, thereby improving debt coverage metrics, would remain a key rating sensitivity. The reliance on mezzanine debt over equity is expected to moderate the company's debt coverage indicators at a consolidated level. The Debt Service Coverage Ratio (DSCR) is projected to remain weak in the current financial year (FY26) and modest thereafter, the agency said. The liquidity position of RRPL (standalone) remains adequate, supported by the new mezzanine debt which enabled it to meet equity contributions for projects. The liquidity position is expected to stay adequate, given plans to raise additional equity in FY26 to fund upcoming projects comfortably, it added.
Mint
16 hours ago
- Mint
Donald Trump threatens to use import restrictions on foreign drugmakers to reduce prices — Does it affect India?
US President Donald Trump on Tuesday threatened to use import restrictions to force foreign suppliers to reduce drug prices. Speaking at the White House at an event with Republican lawmakers, Trump further warned pharma companies to face a 'lot of problems' if they do not agree to reduce the drug prices in the US. Trump pledged to reduce what consumers must pay for prescription drugs. 'Drug companies will have lot of problems if they don't agree to bring prices down,' he said, making hinting at plans to use trade policy as leverage. 'We are going to get drug prices down… We will use import restrictions to force foreign suppliers to cut drug prices.' The US President's statement comes more than a month after he signed a broad executive order in June directing drugmakers to lower the prices of their prescription drugs to align with what other countries pay. The order said the Trump administration will give drugmakers price targets within a month and, if they fail to make "significant progress", may pursue regulatory actions or measures like importing medicines -- though analysts and legal experts say such steps would be difficult to implement. India plays a key role in supplying pharmaceutical products to the US, including generic drugs and active pharmaceutical ingredients (APIs). According to a report by The Times of India, New Delhi supplies around 35 per cent of all generic drugs prescribed in the US. Therefore, Trump's order to force foreign drugmakers to cut drug prices using import restrictions could significantly affect them, coupled with the fact that India and US have not signed a trade deal as yet. However, in June, Crisil Ratings had said Donald Trump's executive order on reducing prescription drug prices will have a limited impact on Indian pharma companies. Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of its pharmaceutical output, the bulk comprises low-priced generic drugs, which already operate on razor-thin margins, leaving little room for further price cuts to materially affect revenues. "API exports (15 per cent of India's pharma exports) are expected to be broadly unaffected, as it is not a major cost for high-margin originator drugs, abating concerns of pricing pressure," the report said. Generic pharma drugs account for 90 per cent of the prescription sales volume but only 13 per cent of the value spending in the US. Generic drug prices in the US are very low and have lower prices in comparison to economically peer countries, it said.
